GNLX - Genelux Corp
IEX Last Trade
2.14
0.160 7.477%
Share volume: 387,626
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.98
0.16
8.08%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2023-05-15 | 2023-08-14 | 2023-11-14 | 2024-03-29 | 2024-05-09 | |
| Total revenue | 170.000 K | 0.000 | 0.000 | 0.000 | 8.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 170.000 K | 0.000 | 0.000 | 0.000 | 8.000 K | |
| -100.00% | nan% | nan% | inf% | |||
| Operating expenses | 6.632 M | 5.395 M | 5.307 M | 7.001 M | 8.123 M | |
| Selling general and admin | 3.787 M | 2.452 M | 2.488 M | 2.841 M | 4.113 M | |
| Research and development | 2.845 M | 2.943 M | 2.819 M | 4.160 M | 4.010 M | |
| Total expenses | 6.632 M | 5.395 M | 5.307 M | 7.001 M | 8.123 M | |
| -18.65% | -1.63% | 31.92% | 16.03% | |||
| Operating income | -6.462 M | -5.395 M | -5.307 M | -7.001 M | -8.115 M | |
| Ebit | -6.462 M | -5.395 M | -5.307 M | -7.001 M | -8.115 M | |
| Pretax income | -10.364 M | -5.821 M | -5.345 M | -6.767 M | -7.850 M | |
| -43.83% | -8.18% | 26.60% | 16.00% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -10.364 M | -5.821 M | -5.345 M | -6.767 M | -7.850 M | |
| 43.83% | 8.18% | -26.60% | -16.00% | |||
| Net income | -10.364 M | -5.821 M | -5.345 M | -6.767 M | -7.850 M | |
| 43.83% | 8.18% | -26.60% | -16.00% |